Perioperative medicine & outcomes

Estimation of the maximum potential cost saving from reducing serious adverse events in hospitalized patients

Acta Anaesthesiol ScandPublished Registry-based matched cohort study with cost estimation

An erratum to this article was published (Acta Anaesthesiol Scand, Feb 2026 ↗)

Authors' conclusion

Reductions in serious adverse events are associated with decreased healthcare costs due to reduced length of stay and avoided readmissions.

Study context

Population
Adult in-hospital patients, Danish national registries
Exposure
Exposed vs not exposed to serious adverse events during admission
Outcome
Difference in LOS and probability of readmission; maximum potential cost savings
Methodological detailscoarsened exact matching, Danish national registries
  • Coarsened exact matching
  • Danish national registries

Main finding

As reported in the abstract

Each group vs not exposedHigher odds of readmissions (95% CI)
Exposed
14%(11%–17%)
Exposed
additional hospital bed days 2.4 days (95% CI 2.4–2.5)

Observational data: associations, not effects.

Further findings

Maximum potential savings per patient avoiding a serious adverse event (base case scenario)

EUR

Reduced LOS
2040
Avoided readmissions
43

Original publication

Estimation of the maximum potential cost saving from reducing serious adverse events in hospitalized patients. Acta Anaesthesiol Scand. Published 25 September 2024. doi:10.1111/aas.14525

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.